抑郁性失眠的药物治疗进展(Progress in the treatment of depressive insomnia).docVIP

抑郁性失眠的药物治疗进展(Progress in the treatment of depressive insomnia).doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
抑郁性失眠的药物治疗进展(Progress in the treatment of depressive insomnia)

抑郁性失眠的药物治疗进展(Progress in the treatment of depressive insomnia) Depressive insomnia was associated with depression in somatic symptoms, the main features of REM sleep latency, wake up early, deep sleep, and REM sleep, wake up less difficult to fall asleep again, every night sleep time was significantly reduced the severity of insomnia usually have a direct relationship with the severity of depression, so the treatment of insomnia can not simply use sleeping pills or behavioral therapy, more important is the treatment of depression. Through comparing several antidepressants, this article discusses the drug treatment of depressive insomnia. 1 drug therapy Monoamine oxidase inhibitors (MAOI), is a drug with selective inhibition of monoamine oxidase activity in vivo, its mechanism is through inhibition of monoamine oxidase activity, reduce the degradation of monoamine neurotransmitters in central nervous system, relative increase of monoamine neurotransmitter levels, resulting in antidepressant effect. This drug is applied to a class of earlier clinical antidepressants are iproniazid, phenelzine and other drugs, but because of more adverse reactions, and the effect is not as good as later tricyclic antidepressants, the clinical use of less than. In recent years, developed a new type of selective monoamine oxidase A inhibitor, on behalf of the drug for moclobemide, its pharmacological effects of selective inhibition of MAOA, and the inhibition is reversible, no cholinergic receptor blockade, retained the antidepressant effect, adverse reaction and abandon the traditional TCA MAOI anticholinergic adverse reaction, its anti depression effect of rapid onset, low adverse reactions, is a safe and effective antidepressant. Tricyclic antidepressants (TCA), which belongs to the first generation of monoamine reuptake inhibitors, 5-HT and NE can not only inhibit the presynaptic reuptake, and with anticholinergic effects, applicable to all types of depression, and the curative effec

文档评论(0)

jgx3536 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6111134150000003

1亿VIP精品文档

相关文档